Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public safety alert following notification from the South African Health Products Regulatory Authority (SAHPRA) regarding the recall of specific batches of Citro-Soda Regular antacid due to potential contamination risks at the manufacturing facility.
Key takeaways
- SAHPRA recalled specific batches of Citro-Soda Regular following contamination risk identification at Adcock Ingram facility
- NAFDAC has issued precautionary alert to Nigerian healthcare providers and consumers
- The recall affects batches manufactured at the Clayville facility in Johannesburg
Manufacturing Facility Contamination Prompts Recall
The recall was initiated after potential contamination risks were identified at the Adcock Ingram Clayville manufacturing facility in Johannesburg, according to NAFDAC’s public alert. Citro-Soda Regular is an effervescent urinary alkalinizer and gastric antacid commonly used for treating acid-related stomach conditions.
SAHPRA’s notification to international regulatory partners, including NAFDAC, demonstrates the coordinated approach to pharmaceutical safety across African regulatory authorities. This inter-agency communication helps ensure rapid dissemination of safety information across regional markets where these products may be distributed.
NAFDAC Advises Caution for Nigerian Market
While the recall specifically targets the South African market, NAFDAC has issued the alert as a precautionary measure for Nigerian healthcare providers and consumers who may have access to these products through various distribution channels. The agency emphasizes the importance of checking batch numbers before use.
Healthcare professionals are advised to verify the source and batch information of Citro-Soda products in their facilities. Patients currently using Citro-Soda Regular are encouraged to check with their healthcare providers regarding alternative antacid options if concerned about product safety.
NAFDAC maintains vigilant monitoring of international drug recalls that may affect Nigerian consumers through cross-border pharmaceutical trade.
— NAFDAC Public Alert No. 025/2026
What this means
Frequently asked questions
What should I do if I have Citro-Soda Regular at home?
Check the batch number and manufacturing location on your product packaging. If manufactured at the Adcock Ingram Clayville facility, consult your healthcare provider about alternative antacid options.
Is Citro-Soda available in Nigerian pharmacies?
While primarily marketed in South Africa, some batches may be available through import channels. NAFDAC’s alert serves as a precautionary measure for any products that may have entered the Nigerian market.
What are the contamination risks mentioned in the recall?
NAFDAC’s alert references potential contamination identified at the manufacturing facility, though specific details of the contamination type were not provided in the public notification.
This alert underscores the importance of robust pharmaceutical surveillance systems and international regulatory cooperation in maintaining drug safety standards. NAFDAC continues to monitor international recalls and safety alerts that may impact Nigerian consumers, ensuring timely communication of potential risks through official channels.
Was this article helpful?
Related Coverage
